Stocks · News reference
8-K filing — Guardian Pharmacy Services, Inc. (GRDN)
Filed: 2026-08-06 AccNo: 0001193125-26-338032 Size: 331 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- edgar
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Guardian Pharmacy Services shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY26 sales guidance above estimates. Also, Oppenheimer maintained an Outperform rating on the stock and raised its price target from $43 to $49.
Oppenheimer Maintains Outperform on Guardian Pharmacy Service, Raises Price Target to $49
Oppenheimer analyst Michael Wiederhorn maintains Guardian Pharmacy Service (NYSE:GRDN) with a Outperform and raises the price target from $43 to $49.
Guardian Pharmacy Service Q2 Adj. EPS $0.29 Beats $0.27 Estimate, Sales $351.768M Beat $340.045M Estimate
Guardian Pharmacy Service (NYSE:GRDN) reported quarterly earnings of $0.29 per share which beat the analyst consensus estimate of $0.27 by 7.41 percent. This is a 26.09 percent increase over earnings of $0.23 per share